The high performance microcatheter is designed for use in highly stenosed lesions for guidewire support, wire exchange and contrast injections during complex coronary and peripheral interventional procedures.
Volcano says that it is the first device to use its proprietary VeriTorque technology and is available in sizes compatible with 0.014" and 0.035" guidewires and in lengths of 100cm, 135cm and 150cm.
The technology also provides torque performance and helps physicians to precisely control and position the guidewire in distal and tortuous anatomy, when combined with Valet’s shapeable distal tip, according to the company.
St Luke’s Mid America Heart Institute interventional cardiology research programme director Dr Barry Rutherford said, "Valet offers compelling performance benefits in challenging peripheral endovascular cases."
Clear Lake Regional Medical Center cardiothoracic surgeon Dr Christos Katsigiannis said, "I particularly appreciated Valet’s performance in navigating the complex anatomy below-the-knee."
